JP2017506882A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017506882A5 JP2017506882A5 JP2016546026A JP2016546026A JP2017506882A5 JP 2017506882 A5 JP2017506882 A5 JP 2017506882A5 JP 2016546026 A JP2016546026 A JP 2016546026A JP 2016546026 A JP2016546026 A JP 2016546026A JP 2017506882 A5 JP2017506882 A5 JP 2017506882A5
- Authority
- JP
- Japan
- Prior art keywords
- adjacent
- cell
- sequence
- membrane
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461929651P | 2014-01-21 | 2014-01-21 | |
| US61/929,651 | 2014-01-21 | ||
| PCT/US2015/012160 WO2015112541A2 (en) | 2014-01-21 | 2015-01-21 | Cellular platform for rapid and comprehensive t-cell immunomonitoring |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017506882A JP2017506882A (ja) | 2017-03-16 |
| JP2017506882A5 true JP2017506882A5 (enExample) | 2018-03-01 |
| JP6875126B2 JP6875126B2 (ja) | 2021-05-19 |
Family
ID=53682115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016546026A Expired - Fee Related JP6875126B2 (ja) | 2014-01-21 | 2015-01-21 | 迅速かつ包括的なｔ細胞免疫モニタリング用の細胞プラットフォーム |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20170176435A1 (enExample) |
| EP (1) | EP3096774B1 (enExample) |
| JP (1) | JP6875126B2 (enExample) |
| KR (1) | KR102488477B1 (enExample) |
| CN (1) | CN106132428B (enExample) |
| AU (1) | AU2015209540B2 (enExample) |
| BR (1) | BR112016016937A8 (enExample) |
| CA (1) | CA2936352A1 (enExample) |
| IL (1) | IL246685B (enExample) |
| SG (1) | SG11201605632SA (enExample) |
| WO (1) | WO2015112541A2 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10048271B2 (en) | 2012-12-11 | 2018-08-14 | Albert Einstein College Of Medicine, Inc. | Methods for high throughput receptor:ligand identification |
| US11505591B2 (en) | 2016-05-18 | 2022-11-22 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| AU2017266905B2 (en) | 2016-05-18 | 2022-12-15 | Albert Einstein College Of Medicine, Inc. | Variant PD-L1 polypeptides, T-cell modulatory multimeric polypeptides, and methods of use thereof |
| KR102760578B1 (ko) | 2016-12-22 | 2025-02-03 | 큐 바이오파마, 인크. | T-세포 조절 다량체 폴리펩타이드 및 이의 사용 방법 |
| US11851471B2 (en) | 2017-01-09 | 2023-12-26 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| IL269000B2 (en) | 2017-03-15 | 2024-06-01 | Cue Biopharma Inc | Methods for modulating an immune response |
| US11407806B2 (en) * | 2017-04-06 | 2022-08-09 | Albert Einstein College Of Medicine | Precision activation of HIV-specific CTLS to eliminate reactivated latent T cells |
| GB201706121D0 (en) | 2017-04-18 | 2017-05-31 | Glaxosmithkline Ip Dev Ltd | Stable cell lines for retroviral production |
| CN107099603A (zh) * | 2017-05-31 | 2017-08-29 | 成都克里斯博生物科技有限公司 | 肿瘤免疫t细胞检测试剂盒和检测方法 |
| EA202090471A1 (ru) * | 2017-09-07 | 2020-06-10 | Кью Биофарма, Инк. | Модулирующие т-клетки мультимерные полипептиды и способы их применения |
| TW201920249A (zh) | 2017-09-07 | 2019-06-01 | 美商信號生物製藥公司 | 具有結合位點之t細胞調節多聚體多肽及其使用方法 |
| CN111886241A (zh) | 2018-01-09 | 2020-11-03 | 库尔生物制药有限公司 | 多聚体t细胞调节多肽及其使用方法 |
| MX2021009640A (es) | 2019-02-12 | 2021-10-13 | Pact Pharma Inc | Composiciones y metodos para la identificacion de celulas t especificas de antigenos. |
| US12061187B2 (en) | 2019-05-23 | 2024-08-13 | Massachusetts Institute Of Technology | Ligand discovery and gene delivery via retroviral surface display |
| WO2021178975A1 (en) * | 2020-03-06 | 2021-09-10 | Albert Einstein College Of Medicine | A method to generate chimeric antigen receptor (car) t-cells (car-t cells) from pathogen-specific cytotoxic lymphocytes to enable the subsequent in vivo modulation of their functional activity |
| WO2021231376A2 (en) | 2020-05-12 | 2021-11-18 | Cue Biopharma, Inc. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| EP4211149A4 (en) | 2020-09-09 | 2024-10-09 | Cue Biopharma, Inc. | MULTIMERIC POLYPEPTIDES MODULATING MHC CLASS II T CELLS FOR THE TREATMENT OF TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF |
| EP4281569A4 (en) * | 2021-01-25 | 2025-04-02 | The Regents Of The University Of California | Methods and compositions for labeling and selecting antigen-specific T cells |
| AU2022227021A1 (en) | 2021-02-26 | 2023-09-21 | Kelonia Therapeutics, Inc. | Lymphocyte targeted lentiviral vectors |
| CA3236366A1 (en) * | 2021-10-27 | 2023-05-04 | Xiaojun Lian | Universal stem cell and uses thereof |
| IL327308A (en) | 2023-09-25 | 2026-05-01 | Kelonia Therapeutics Inc | Antigen-binding polypeptides |
| AU2024353718A1 (en) | 2023-09-25 | 2026-04-09 | Kelonia Therapeutics, Inc. | Compositions for treating cancer |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1287363A2 (en) * | 2000-05-25 | 2003-03-05 | Sunol Molecular Corporation | Modulation of t-cell receptor interactions |
| US20040161817A1 (en) * | 2001-06-04 | 2004-08-19 | Corixa Corporation | Compositions and methods for high-level, large-scale production of recombinant proteins |
| US20030017134A1 (en) * | 2001-06-19 | 2003-01-23 | Technion Research And Development Foundation Ltd. | Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| US8895020B2 (en) * | 2002-04-19 | 2014-11-25 | Washington University | Single chain trimers and uses therefor |
| AU2003901876A0 (en) * | 2003-04-17 | 2003-05-08 | The Macfarlane Burnet Institute For Medical Research And Public Health | Viral vector |
| AU2005247950B2 (en) * | 2004-05-27 | 2012-02-02 | Receptor Logic, Inc. | Antibodies as T cell receptor mimics, methods of production and uses thereof |
| ZA200810677B (en) * | 2006-05-19 | 2010-03-31 | Teva Pharma | Fusion proteins, uses thereof and processes for producing same |
| EP1889851A1 (en) * | 2006-08-18 | 2008-02-20 | Charite Universitätsmedizin-Berlin | PAX2 and PAX8 as targets for immunologic and molecular tumour treatment strategies |
| EP2184070A1 (en) * | 2008-11-07 | 2010-05-12 | Hla-G Technologies | HLA-G proteins and pharmaceutical uses thereof |
| WO2012127464A2 (en) * | 2011-03-23 | 2012-09-27 | Gavish-Galilee Bio Applications Ltd | Constitutively activated t cells for use in adoptive cell therapy |
| WO2014083004A1 (en) * | 2012-11-30 | 2014-06-05 | Roche Glycart Ag | Removal of cancer cells by circulating virus-specific cytotoxic t-cells using cancer cell targeted mhc class i comprising multi-function proteins |
-
2015
- 2015-01-21 SG SG11201605632SA patent/SG11201605632SA/en unknown
- 2015-01-21 BR BR112016016937A patent/BR112016016937A8/pt not_active Application Discontinuation
- 2015-01-21 JP JP2016546026A patent/JP6875126B2/ja not_active Expired - Fee Related
- 2015-01-21 CN CN201580011839.8A patent/CN106132428B/zh not_active Expired - Fee Related
- 2015-01-21 US US15/110,384 patent/US20170176435A1/en not_active Abandoned
- 2015-01-21 CA CA2936352A patent/CA2936352A1/en active Pending
- 2015-01-21 KR KR1020167022488A patent/KR102488477B1/ko active Active
- 2015-01-21 EP EP15740849.3A patent/EP3096774B1/en active Active
- 2015-01-21 AU AU2015209540A patent/AU2015209540B2/en not_active Ceased
- 2015-01-21 WO PCT/US2015/012160 patent/WO2015112541A2/en not_active Ceased
-
2016
- 2016-07-10 IL IL246685A patent/IL246685B/en active IP Right Grant
-
2022
- 2022-05-27 US US17/827,024 patent/US20230052675A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102488477B1 (ko) | 신속하고 포괄적인 t-세포 면역 모니터링을 위한 세포 플랫폼 | |
| JP7559029B2 (ja) | 形質導入のための方法、キット、作用物質および装置 | |
| AU2024202172B2 (en) | Peptide-mhc compacts | |
| JP7556583B2 (ja) | Ｋｒａｓ突然変異を識別するｔ細胞受容体およびそのコード配列 | |
| JP7221049B2 (ja) | レンチウイルス調製物の安定化のための緩衝液 | |
| AU2005247598B2 (en) | Tumor-associated peptides that bind to MHC-molecules | |
| WO2020063488A1 (zh) | 一种识别ssx2抗原的t细胞受体 | |
| KR20210126073A (ko) | 항원 특이적 t 세포의 식별을 위한 조성물 및 방법 | |
| JP2022515331A5 (enExample) | ||
| CN105131126A (zh) | 用于治疗恶性肿瘤的嵌合抗原受体及其制备方法与应用 | |
| HRP20192262T1 (hr) | Nova imunoterapija protiv nekoliko tumora, kao što su rak pluća, uključujući mikrocelularni karcinom pluća (nsclc) | |
| WO2020024915A1 (zh) | 一种识别afp抗原的t细胞受体 | |
| CN110343166A (zh) | 识别afp抗原短肽的t细胞受体 | |
| Schafer et al. | KIR3DL01 recognition of Bw4 ligands in the rhesus macaque: maintenance of Bw4 specificity since the divergence of apes and Old World monkeys | |
| WO2022187289A1 (en) | Methods and compositions for the delivery of retroviral particles | |
| CN110577591A (zh) | 一种识别afp抗原短肽的t细胞受体及其编码序列 | |
| CN111848818A (zh) | 一种增强型免疫细胞及其应用 | |
| CN116981684A (zh) | 一种纳米颗粒及其检测car阳性表达率的应用 | |
| CN113072636B (zh) | 一种识别afp的t细胞受体及其编码序列 | |
| WO2018053374A2 (en) | Methods and compositions for t-cell epitope screening | |
| US20250297282A1 (en) | Viral-binding protein and related reagents, articles, and methods of use | |
| US20220184130A1 (en) | Artificial signalling molecule | |
| CN109957017A (zh) | 一种靶向ox40的单链抗体、嵌合抗原受体t细胞及其制备方法和应用 | |
| CN109575120B (zh) | 识别prame抗原短肽的tcr及其编码序列 | |
| CN119798408B (zh) | 一种识别hpv多抗原表位的tcr及其编码序列 |